Tpiao

Tpiao

Manufacturer:

Shenyang Sunshine

Distributor:

Goodfellow
Concise Prescribing Info
Contents
Recombinant human thrombopoietin
Indications/Uses
Management of thrombocytopenia in patients receiving myelosuppressive or myeloablative chemotherapy & in HIV-associated thrombocytopenia.
Dosage/Direction for Use
Given SC 6-24 hr after chemotherapy. 300 u/kg once everyday continually for 14 days.
Contraindications
Severe cardio-cerebral vascular angiopathy, blood agglutination or history of thrombosis.
Special Precautions
Blood routine exam made at fixed period. Pregnancy & lactation.
Adverse Reactions
Fever, shiver, discomfort from head to foot, fatigue, knee arthralgia, headache, dizziness, HTN.
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA - Other antianemic preparations ; Used in the treatment of anemia.
Presentation/Packing
Form
Tpiao inj 15000 IU/mL
Packing/Price
(vial) 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in